These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 524148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factor VIII inhibitors in hemophilia.
    Mariani G.
    Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
    [No Abstract] [Full Text] [Related]

  • 3. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K, Fujimari M, Ukita M, Kitahara T.
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L.
    ASDC J Dent Child; 1979 Dec; 46(1):54-6. PubMed ID: 283081
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM, Ménaché D, Roberts HR.
    Thromb Haemost; 1980 Aug 29; 44(1):39-42. PubMed ID: 6775386
    [Abstract] [Full Text] [Related]

  • 10. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K, Nowotny C, Krinninger B, Zegner M, Deutsch E.
    Thromb Haemost; 1979 Feb 15; 40(3):478-85. PubMed ID: 425062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factor VIII inhibitors.
    Gilles JG, Jacquemin MG, Saint-Remy JM.
    Thromb Haemost; 1997 Jul 15; 78(1):641-6. PubMed ID: 9198231
    [No Abstract] [Full Text] [Related]

  • 14. A randomized study of factor VIII or prothrombin complex concentrate infusions in children with haemophilia and antibodies to factor VIII.
    Ekert H, Price DA, Lane JL, Dean FL.
    Aust N Z J Med; 1979 Jun 15; 9(3):241-4. PubMed ID: 288389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of hemophilia patients with inhibitors.
    Hedner U, Glazer S.
    Hematol Oncol Clin North Am; 1992 Oct 15; 6(5):1035-46. PubMed ID: 1400071
    [Abstract] [Full Text] [Related]

  • 18. Suggestions for the management of factor VIII inhibitors.
    Rubinger M, Rivard GE, Teitel J, Walker H, Inhibitor Subcommittee of the Association of Hemophilia Clinic Directors of Canada.
    Haemophilia; 2000 Jul 15; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep 15; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

  • 20. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT, Lee CA.
    Thromb Haemost; 1999 May 15; 81(5):852. PubMed ID: 10365768
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.